Similar articles

• Leukemia in atomic bomb survivors, Hiroshima and Nagasaki, 1 October 1950--30 September 1966.

  Ishimaru T, Hoshino T, Ichimaru M, Okada H, Tomiyasu T. Ishimaru T, et al. Radiat Res. 1971 Jan;45(1):216-33. Radiat Res. 1971. PMID: 5275936 No abstract available.
• Review of thirty years study of Hiroshima and Nagasaki atomic bomb survivors. II. Biological effects. D. Leukemia and related disorders.

  Ichimaru M, Ishimaru T. Ichimaru M, et al. J Radiat Res. 1975 Sep;16 Suppl:89-96. doi: 10.1269/jrr.16.supplement_89. J Radiat Res. 1975. PMID: 1104825 Review. No abstract available.
• Dose-response relationship of neutrons and gamma rays to leukemia incidence among atomic bomb survivors in Hiroshima and Nagasaki by type of leukemia, 1950--1971.

  Ishimaru T, Otake M, Ischimaru M. Ishimaru T, et al. Radiat Res. 1979 Feb;77(2):377-94. Radiat Res. 1979. PMID: 286375 No abstract available.
• Incidence of leukemia in atomic bomb survivors belonging to a fixed cohort in Hiroshima and Nagasaki, 1950--71. Radiation dose, years after exposure, age at exposure, and type of leukemia.

  Ichimaru M, Ishimaru T, Belsky JL. Ichimaru M, et al. J Radiat Res. 1978 Sep;19(3):262-82. doi: 10.1269/jrr.19.262. J Radiat Res. 1978. PMID: 739446 No abstract available.
• Radiation-induced leukemia: lessons from history.

  Finch SC. Finch SC. Best Pract Res Clin Haematol. 2007 Mar;20(1):109-18. doi: 10.1016/j.beha.2006.10.009. Best Pract Res Clin Haematol. 2007. PMID: 17336261 Review.